Novate

Galway, Ireland Founded: 2006 • Age: 20 yrs Acquired By BTG International
Inferior vena cava filters are developed for pulmonary embolism treatment.

About Novate

Novate is a Healthcare company based in Galway (Ireland) founded in 2006, and was acquired by BTG International in September 2018. Inferior vena cava filters are developed for pulmonary embolism treatment. Novate has raised $17.97 million across 2 funding rounds from investors including Enterprise Ireland, BTG International and Omnes Capital. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices.

Company details

Novate Medical was founded in 2006 in Galway, Ireland, and operates in the medical device sector. Focus is placed on inferior vena cava filters for pulmonary embolism prevention in high-risk patients. The lead product, Sentry, is a bio-convertible filter that provides protection during the high-risk period and bioconverts to an unobstructed lumen after at least 60 days. Enrollment in its FDA trial has been completed in the US and Europe.

Operational Areas
Key Metrics

Funding Insights of Novate

Novate has successfully raised a total of $17.97M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.42 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $17.97M
  • Total Rounds 2
  • Last Round Series B β€” $12.42M
  • First Round $5.55M

    (Sep 2007)

  • Investors Count 4

All 2 funding rounds of Novate with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2011$12.42MSeries B–Omnes Capital, Seroba Life Sciences
Sep 2007$5.55MSeries A–Act Venture Capital
Valuation history

5 investors in total: 5 institutional.

Investors in Novate

Novate has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, BTG International and Omnes Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity firm focused on energy transition and sustainable investments across Europe.
omnescapital.com
Early-stage venture capital funding is provided to innovative companies.
actventure.capitalDublin, Ireland
Seroba Lifesciences is focused on life sciences venture capital investments.
seroba-lifesciences.comDublin, Ireland
Support is provided to Irish manufacturing and service sector businesses.
1998enterprise-ireland.comDublin, Ireland
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments.
1948btgplc.comLondon, United Kingdom
Premium access

Investor details for Novate

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Novate

1150 people are tracked at Novate (315 in leadership, 9 in board & advisors, 826 in team).

NameRoleGroup
Augusto Chaves
IT PMO & Finance HeadLeadership
Genevieve Morrison
IT Director, Acquisition & IntegrationsLeadership
David Sapienza
VP Global Operation Distribution And LogisticsLeadership
Nikunj Murgai
Director, ITLeadership
Jodi Eddy
Senior Vice President, Enterprise Services and Digital OfficerLeadership
Siri Thompson
Vice President, Program Management LAACLeadership
Lance Bates
SVP & President, Interventional Cardiology TherapiesLeadership
Alex Pflugfelder
Director - Upstream EP Marketing, EP Commercial Development TeamLeadership
Sofía Leiva
HR Specialist - People Services Partner LatamLeadership
Zoe Heuver
Supply Chain PartnerLeadership
Charles K.
Director, QualityLeadership
Ahmed Abdelaal
Chief Medical OfficerLeadership
Lillian Kerrigan
Director Global Quality Design Controls And AcquisitionsLeadership
Viktoriya Skuz
People Partner ILeadership
Kelly Schwenn
Director Of Program Management, Arden Hills And North America ManufacturingLeadership
Charudatta Aradhye
Associate Director, R&DLeadership
Sandra Nagale
Director, Digital Health Products, Platforms & AILeadership
Gary Leblanc
Director Of QualityLeadership
Janet Bukovcan
Director, Regulatory AffairsLeadership
Philip Sinclair
Vice President, Global Medical Affairs And Clinical Development, Interventional OncologyLeadership

1130 more people are available in the full profile.

Premium access

Complete people profiles for Novate

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Novate

4 dated milestones of Novate across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Novate is founded.
  2. Funding First funding round of $5.5M.
  3. Funding Latest funding round, Series B, of $12.4M.
  4. Exit Acquired by BTG International.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Novate

Novate Raises VC - PE Hub
Pehub β€’ 19 years ago
Premium access

Complete news archive for Novate

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Novate

Novate was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Novate is headquartered in Galway, Ireland.

Novate is a funded company, having raised a total of $17.97M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.55M, raised on Sep 2007.

Novate Medical was founded in 2006 in Galway, Ireland, and operates in the medical device sector. Focus is placed on inferior vena cava filters for pulmonary embolism prevention in high-risk patients. The lead product, Sentry, is a bio-convertible filter that provides protection during the high-risk period and bioconverts to an unobstructed lumen after at least 60 days. Enrollment in its FDA trial has been completed in the US and Europe.

Novate has 5 investors. Key investors include Enterprise Ireland, BTG International, Omnes Capital, Seroba Lifesciences, and Act Venture Capital.

Yes. Novate was acquired by BTG International in September 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available